My Sjogren's Clinical Trial Experience: A Doctor & Patient Perspective | Dazodalibep & OASIZ Trial

Описание к видео My Sjogren's Clinical Trial Experience: A Doctor & Patient Perspective | Dazodalibep & OASIZ Trial

Join Dr. Kara Wada as she shares her deeply personal experience participating in the OASIZ clinical trial for Sjogren's disease, a condition she lives with herself. In this candid and informative video, Dr. Kara discusses her motivations for joining the trial, the process involved (from initial screening to ongoing infusions), and, most importantly, her results after six months.

She answers common questions about clinical trial safety, the double-blind placebo-controlled design, and the potential benefits and side effects of Dazodalibep, a CD40 ligand blocker. Dr. Kara also emphasizes the importance of patient-centered care, her commitment to empowering others through knowledge, and the hope these clinical trials offer for the future of Sjogren's treatment.

Whether you're considering joining a clinical trial or simply curious about the process, Dr. Kara's personal journey offers valuable insights and inspiration. Don't forget to connect with the Sjogren's community! 👇

Be the First to Hear When My Private Practice Opens. Join the waitlist for Dr. Kara Wada's integrative, personalized approach to immune wellness → https://www.drkarawada.com/immune-con...

RESOURCES:

Download Dr. Kara’s FREE Immune System Disorders Pre-Appointment Checklist to prepare for your next doctor's visit: https://www.drkarawada.com/master-you...

Join the Success with Sjogren's Sisterhood Facebook group for support and connection →  / successwithsjogrens  

Download your free Sjogren’s Starter Kit for helpful resources → https://www.drkarawada.com/sjogrens-s...

CONNECT WITH DR. KARA
Website → https://www.drkarawada.com/
LinkedIn →   / karawadamd  
Instagram →   / immuneconfidentmd  
Podcast Instagram →   / becomingimmuneconfident  
Facebook →   / karawadamd  
Twitter →   / crunchyallergy  
TikTok →   / immuneconfident  

Комментарии

Информация по комментариям в разработке